Persistent hypomethylation in the promoter of nucleosomal binding protein 1 (Nsbp1) correlates with overexpression of Nsbp1 in mouse uteri neonatally exposed to diethylstilbestrol or genistein

Endocrinology

Volumn 149, Issue 12, 2008, Pages 5922-5931

  Tang, Wan Yee ^a,b   Newbold, Retha ^c   Mardilovich, Katerina ^b   Jefferson, Wendy ^c   Cheng, Robert Y S ^b,e   Medvedovic, Mario ^a   Ho, Shuk Mei ^a,b,d  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^d UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIETHYLSTILBESTROL; GENISTEIN;

ADENOCARCINOMA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHROMATIN ASSEMBLY AND DISASSEMBLY; CONTROLLED STUDY; CPG ISLAND; DNA FINGERPRINTING; DNA METHYLATION; EPIGENETICS; FEMALE; GENE; GENE EXPRESSION; GENE MUTATION; GENE OVEREXPRESSION; GENE SEQUENCE; MOLECULAR INTERACTION; MOLECULAR MECHANICS; MOUSE; NEWBORN; NONHUMAN; NUCLEOSOMAL BINDING PROTEIN 1 GENE; OVARIECTOMY; PRIORITY JOURNAL; PROMOTER REGION; PUBERTY; UTERUS; UTERUS CARCINOMA;

ANIMALS; ANIMALS, NEWBORN; CLUSTER ANALYSIS; DIETHYLSTILBESTROL; DNA METHYLATION; FEMALE; GENE EXPRESSION; GENISTEIN; HMGN PROTEINS; MALE; MICE; OVARIECTOMY; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; UTERUS;

EID: 57349126317     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2008-0682     Document Type: Article

References (57)

1. Sinclair KD, Lea RG, Rees WD, Young LE 2007 The developmental origins of health and disease: current theories and epigenetic mechanisms. Soc Reprod Fertil Suppl 64:425-443
2. Tang WY, Ho SM 2007 Epigenetic reprogramming and imprinting in origins of disease. Rev Endocr Metab Disord 8:173-182
3. McLachlan JA, Simpson E, Martin M 2006 Endocrine disrupters and female reproductive health. Best Pract Res Clin Endocrinol Metab 20:63-75
4. Prins GS, Huang L, Birch L, Pu Y 2006 The role of estrogens in normal and abnormal development of the prostate gland. Ann NY Acad Sci 1089:1-13
5. Keri RA, Ho SM, Hunt PA, Knudsen KE, Soto AM, Prins GS 2007 An evaluation of evidence for the carcinogenic activity of bisphenol A. Reprod Toxicol 24:240-252
6. Ho SM, Tang WY 2007 Techniques used in studies of epigenome dysregulation due to aberrant DNA methylation: an emphasis on fetal-based adult diseases. Reprod Toxicol 23:267-282
7. Hilakivi-Clarke L 2007 Nutritional modulation of terminal end buds: its relevance to breast cancer prevention. Curr Cancer Drug Targets 7:465-474
8. Woodruff TK, Walker CL 2008 Fetal and early postnatal environmental exposures and reproductive health effects in the female. Fertil Steril 89(Suppl):e47-e51
9. Herbst AL, Ulfelder H, Poskanzer DC 1971 Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med 284:878-881
10. Herbst AL, Kurman RJ, Scully RE 1972 Vaginal and cervical abnormalities after exposure to stilbestrol in utero. Obstet Gynecol 40:287-298
11. Herbst AL, Bern HA 1981 Developmental effects of diethylstilbestrol (DES) in pregnancy. New York: Thieme-Stratton
12. Hammes B, Laitman CJ 2003 Diethylstilbestrol (DES) update: recommendations for the identification and management of DES-exposed individuals. J Midwifery Womens Health 48:19-29
13. NIH 1999 DES Research Update No. 00-4722. Bethesda, MD: NIH Publication
14. Giusti RM, Iwamoto K, Hatch EE 1995 Diethylstilbestrol revisited: a review of the long-term health effects. Ann Intern Med 122:778-788
15. Palmer JR, Hatch EE, Rosenberg CL, Hartge P, Kaufman RH, Titus-Ernstoff L, Noller KL, Herbst AL, Rao RS, Troisi R, Colton T, Hoover RN 2002 Risk of breast cancer in women exposed to diethylstilbestrol in utero: preliminary results (United States). Cancer Causes Control 13:753-758
16. Henderson BE, Benton B, Cosgrove M, Baptista J, Aldrich J, Townsend D, Hart W, Mack TM 1976 Urogenital tract abnormalities in sons of women treated with diethylstilbestrol. Pediatrics 58:505-507
17. Klip H, Verloop J, van Gool JD, Koster ME, Burger CW, van Leeuwen FE 2002 Hypospadias in sons of women exposed to diethylstilbestrol in utero: a cohort study. Lancet 359:1102-1107
18. Brouwers MM, Feitz WF, Roelofs LA, Kiemeney LA, de Gier RP, Roeleveld N 2007 Risk factors for hypospadias. Eur J Pediatr 166:671-678
19. Warri A, Saarinen NM, Makela S, Hilakivi-Clarke L 2008 The role of early life genistein exposures in modifying breast cancer risk. Br J Cancer 98:1485-1493
20. Badger TM, Ronis MJ, Hakkak R, Rowlands JC, Korourian S 2002 The health consequences of early soy consumption. J Nutr 132:559S-565S
21. Messina M, Barnes S, Setchell KD 1997 Phyto-oestrogens and breast cancer. Lancet 350:971-972
22. Lamartiniere CA, Cotroneo MS, Fritz WA, Wang J, Mentor-Marcel R, Elgavish A 2002 Genistein chemoprevention: timing and mechanisms of action in murine mammary and prostate. J Nutr 132:552S-558S
23. Hilakivi-Clarke L, Cho E, Onojafe I, Raygada M, Clarke R 1999 Maternal exposure to genistein during pregnancy increases carcinogen-induced mammary tumorigenesis in female rat offspring. Oncol Rep 6:1089-1095
24. Newbold RR, Banks EP, Bullock B, Jefferson WN 2001 Uterine adenocarcinoma in mice treated neonatally with genistein. Cancer Res 61:4325-4328
25. Jefferson WN, Padilla-Banks E, Newbold RR 2007 Disruption of the female reproductive system by the phytoestrogen genistein. Reprod Toxicol 23:308-316
26. Burroughs CD, Mills KT, Bern HA 1990 Reproductive abnormalities in female mice exposed neonatally to various doses of coumestrol. J Toxicol Environ Health 30:105-122
27. Whitten PL, Lewis C, Russell E, Naftolin F 1995 Potential adverse effects of phytoestrogens. J Nutr 125(Suppl):771S-776S
28. 1994 Infant feeding practices and their possible relationship to the etiology of diabetes mellitus. American Academy of Pediatrics Work Group on Cow's Milk Protein and Diabetes Mellitus. Pediatrics 94:752-754
29. American Academy of Pediatrics, Committee on Nutrition 1998 American Academy of Pediatrics. Committee on Nutrition. Soy protein-based formulas: recommendations for use in infant feeding. Pediatrics 101(1 Pt 1):148-53
30. Turck D 2007 Soy protein for infant feeding: what do we know? Curr Opin Clin Nutr Metab Care 10:360-365
31. Newbold RR, Bullock BC, McLachlan JA 1990 Uterine adenocarcinoma in mice following developmental treatment with estrogens: a model for hormonal carcinogenesis. Cancer Res 50:7677-7681
32. Deligdisch L, Holinka CF 1987 Endometrial carcinoma: two diseases? Cancer Detect Prev 10:237-246
33. Li S, Washburn KA, Moore R, Uno T, Teng C, Newbold RR, McLachlan JA, Negishi M 1997 Developmental exposure to diethylstilbestrol elicits demethylation of estrogen-responsive lactoferrin gene in mouse uterus. Cancer Res 57:4356-4359
34. Li S, Hansman R, Newbold R, Davis B, McLachlan JA, Barrett JC 2003 Neonatal diethylstilbestrol exposure induces persistent elevation of c-fos expression and hypomethylation in its exon-4 in mouse uterus. Mol Carcinog 38:78-84
35. Li S, Ma L, Chiang T, Burow M, Newbold RR, Negishi M, Barrett JC, McLachlan JA 2001 Promoter CpG methylation of Hox-a10 and Hox-a11 in mouse uterus not altered upon neonatal diethylstilbestrol exposure. Mol Carcinog 32:213-219
36. Ho SM, Tang WY, Belmonte de Frausto J, Prins GS 2006 Developmental exposure to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant 4. Cancer Res 66:5624-532
37. Thigpen JE, Setchell KD, Ahlmark KB, Locklear J, Spahr T, Caviness GF, Goelz MF, Haseman JK, Newbold RR, Forsythe DB 1999 Phytoestrogen content of purified, open- and closed-formula laboratory animal diets. Lab Anim Sci 49:530-536
38. Huang TH, Laux DE, Hamlin BC, Tran P, Tran H, Lubahn DB 1997 Identification of DNA methylation markers for human breast carcinomas using the methylation-sensitive restriction fingerprinting technique. Cancer Res 57:1030-1034
39. Wu M, Ho SM 2004 PMP24, a gene identified by MSRF, undergoes DNA hypermethylation-associated gene silencing during cancer progression in an LNCaP model. Oncogene 23:250-259
40. Bock C, Reither S, Mikeska T, Paulsen M, Walter J, Lengauer T 2005 BiQ Analyzer: visualization and quality control for DNA methylation data from bisulfite sequencing. Bioinformatics 21:4067-4068
41. Everitt BS 1993 Cluster analysis. London: Edward Arnold
42. Daniel WW 1999 Biostatistics: a foundation for analysis in the health sciences. 7th ed. New York: Wiley
43. Janatpour MJ, McMaster MT, Genbacev O, Zhou Y, Dong J, Cross JC, Israel MA, Fisher SJ 2000 Id-2 regulates critical aspects of human cytotrophoblast differentiation, invasion and migration. Development 127:549-558
44. Salvatierra A, Tarrats A, Gomez C, Sastre JM, Balana C 2006 A case of c-kit positive high-grade stromal endometrial sarcoma responding to imatinib mesylate. Gynecol Oncol 101:545-547
45. Menczer J, Levy T, Piura B, Chetrit A, Altaras M, Meirovitz M, Glezerman M, Fishman A 2005 A comparison between different postoperative treatment modalities of uterine carcinosarcoma. Gynecol Oncol 97:166-170
46. Geller MA, Argenta P, Bradley W, Dusenbery KE, Brooker D, Downs Jr LS, Judson PL, Carson LF, Boente MP 2004 Treatment and recurrence patterns in endometrial stromal sarcomas and the relation to c-kit expression. Gynecol Oncol 95:632-636
47. Leath III CA, Straughn Jr JM, Conner MG, Barnes III MN, Alvarez RD, Partridge EE, Huh WK 2004 Immunohistochemical evaluation of the c-kit proto-oncogene in sarcomas of the uterus: a case series. J Reprod Med 49:71-75
48. Elmore LW, Domson K, Moore JR, Kornstein M, Burks RT 2001 Expression of c-kit (CD117) in benign and malignant human endometrial epithelium. Arch Pathol Lab Med 125:146-151
49. Bustin M, Reeves R 1996 High-mobility-group chromosomal proteins: architectural components that facilitate chromatin function. Prog Nucleic Acid Res Mol Biol 54:35-100
50. Ding HF, Bustin M, Hansen U 1997 Alleviation of histone H1-mediated transcriptional repression and chromatin compaction by the acidic activation region in chromosomal protein HMG-14. Mol Cell Biol 17:5843-5855
51. Shirakawa H, Herrera JE, Bustin M, Postnikov Y 2000 Targeting of high mobility group-14/-17 proteins in chromatin is independent of DNA sequence. J Biol Chem 275:37937-37944
52. Zhu X, Leav I, Leung YK, Wu M, Liu Q, Gao Y, McNeal JE, Ho SM 2004 Dynamic regulation of estrogen receptor-β expression by DNA methylation during prostate cancer development and metastasis. Am J Pathol 164:2003-2012
53. Erdogan G, Bassorgun CI, Pestereli HE, Simsek T, Karaveli S 2007 C-kit protein expression in uterine and ovarian mesenchymal tumours. APMIS 115:204-209
54. Fujii S, Katsumata D, Fujimori T 2008 Limits of diagnosis and molecular markers for early detection of ulcerative colitis-associated colorectal neoplasia. Digestion 77(Suppl 1):2-12
55. Kwabi-Addo B, Chung W, Shen L, Ittmann M, Wheeler T, Jelinek J, Issa JP 2007 Age-related DNA methylation changes in normal human prostate tissues. Clin Cancer Res 13:3796-3802
56. Catez F, Lim JH, Hock R, Postnikov YV, Bustin M 2003 HMGN dynamics and chromatin function. Biochem Cell Biol 81:113-122
57. King LM, Francomano CA 2001 Characterization of a human gene encoding nucleosomal binding protein NSBP1. Genomics 71:163-173